Neurotoxicologists study the effects of toxic substances on the nervous system, investigating how environmental and chemical exposures lead to neurological damage. They focus on identifying neurotoxic agents, such as heavy metals, pesticides, and industrial chemicals, that may contribute to conditions like neuropathy, cognitive impairment, and neurodegenerative diseases. Through experimental and epidemiological studies, neurotoxicologists assess the mechanisms by which these substances interfere with brain function, often leading to long-term neurological consequences. Their work also explores the genetic and environmental factors that may increase susceptibility to neurotoxicity, providing a deeper understanding of vulnerability. Neurotoxicologists collaborate with regulatory agencies to establish safety standards for chemical exposures, influencing policies that protect public health. Their research is instrumental in developing preventive strategies, mitigating the effects of neurotoxic substances, and advancing clinical approaches for individuals already exposed to these risks. Additionally, they explore the cumulative effects of long-term exposure to low levels of neurotoxic substances, assessing the potential for chronic neurological conditions. Neurotoxicologists are essential in developing public health guidelines that reduce the risk of neurotoxic harm in both occupational and environmental settings.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States